WILMINGTON, N.C. – September 20, 2010 -- AAIPharma Services Corp., a leading provider of pharmaceutical product development services for more than 30 years, announced today that it has appointed Philippe M. Maitre as executive vice president and chief financial officer. Mr. Maitre brings to AAIPharma Services 30 years of global financial management experience in the pharmaceutical and biotech industries. Most recently, he was chief financial officer for Oscient Pharmaceuticals, a commercial-stage pharmaceutical company.
Patrick Walsh, CEO of AAIPharma Services, stated, "Philippe brings a wealth of leadership experience to our company. He has managed organizations on a global basis, and will oversee all administrative and financial roles within AAIPharma Services. Philippe possesses a keen financial discipline and excellent business skills that will aid in our company’s expansion initiatives.”
Mr. Maitre has served in multiple senior executive positions around the world, including assignments in Europe and Japan. He was the deputy CFO, corporate controller and corporate treasurer of Rhone-Poulenc Rorer and Aventis (Sanofi-Aventis), and CFO of PPD, Inc., a leading global contract research organization. He also served as CEO of Anosys, a company specializing in oncology. Mr. Maitre began his career with the French Ministry of Foreign Affairs in Libya as the manager of French – Libyan Chamber of Commerce. He holds an advanced degree from Hautes Etudes de Commerce (HEC), the leading French Business School based in Paris.
About AAIPharma Services Corporation
AAIPharma Services Corp. is a leading provider of services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies throughout North America. It is headquartered in Wilmington, North Carolina. For more information on the company, visit www.aaipharma.com.